Oncologic comparison between nonradical management and total mesorectal excision in good responders after chemoradiotherapy in patients with mid-to-low rectal cancer

다국어 초록 (Multilingual Abstract)

Purpose: This study was performed to compare the oncologic outcomes between nonradical management and total mesorectal excision in good responders after chemoradiotherapy.
Methods: We analyzed 75 patients, who underwent 14 watch-and-wait, 30 local excision, and 31 total mesorectal excision, in ycT0–1N0M0 based on magnetic resonance imaging after chemoradiotherapy for advanced mid-to-low rectal cancer in 3 referral hospitals. The nonradical management group underwent surveillance with additional sigmoidoscopy and rectal magnetic resonance imaging every 3–6 months within the first 2 years.
Results: Nonradical management group had more low-lying tumors (P < 0.001) and less lymph node metastasis based on magnetic resonance imaging (P = 0.004). However, cT stage, ycT, and ycN stage were not different between the 2 groups. With a median follow-up period of 64.7 months, the 5-year locoregional failure rate was higher in the nonradical management group than in the total mesorectal excision group (16.7% vs. 0%, P = 0.013). However, the 5-year overall survival and disease-free survival rates of the nonradical management and total mesorectal excision groups were not different (95.2% vs. 93.5%, P = 0.467; 76.4% vs. 83.6%, P = 0.665; respectively).
Conclusion: This study shows that nonradical management for ycT0–1N0 mid-to-low rectal cancer may be an alternative treatment to total mesorectal excision under proper surveillance and management for oncologic events.

목차 (Table of Contents)

• INTRODUCTION
• METHODS
• RESULTS
• DISCUSSION
• REFERENCES

참고문헌 (Reference)

1 Renehan AG, "Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis" 17 : 174-183, 2016

2 Shin YS, "Total mesorectal excision versus local excision after preoperative chemoradiotherapy in rectal cancer with lymph node metastasis: a propensity score-matched analysis" 101 : 630-639, 2018

3 Huang SH, "Selecting stage ypT0-1N0 for locally advanced rectal cancer following preoperative chemoradiotherapy: implications for potential candidates of organ-sparing management" 18 : 989-996, 2016

4 Nie K, "Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI" 22 : 5256-5264, 2016

5 Lai CL, "Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or “watch and wait”" 31 : 413-419, 2016

6 Kang SB, "Quality of life after sphincter preservation surgery or abdominoperineal resection for low rectal cancer (ASPIRE):a long-term prospective, multicentre, cohort study" 6 : 100087-, 2021

7 Sauer R, "Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer:results of the German CAO/ARO/AIO 94 randomized phase III trial after a median follow-up of 11 years" 30 : 1926-1933, 2012

8 Roh MS, "Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03" 27 : 5124-5130, 2009

9 Rullier E, "Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial" 5 : 465-474, 2020

10 Rullier E, "Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, openlabel, multicentre, phase 3 trial" 390 : 469-479, 2017

11 Garcia-Aguilar J, "Organ preservation for clinical T2N0distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2trial" 16 : 1537-1546, 2015

12 Balyasnikova S, "Optimal imaging strategies for rectal cancer staging and ongoing management" 17 : 32-, 2016

13 Jeong SY, "Open versus laparoscopic surgery for mid-rectal or low- rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial" 15 : 767-774, 2014

14 Shaikh I, "Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis" 30 : 19-29, 2015

15 Dattani M, "Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis" 268 : 955-967, 2018

16 Song KS, "Oncologic risk of rectal preservation against medical advice after chemoradiotherapy for rectal cancer: a multicenter comparative cross-sectional study with rectal preservation as supported by surgeon" 43 : 3216-3223, 2019

17 Wook Hyeon Yoon, "Oncologic impact of pathologic response on clinical outcome after preoperative chemoradiotherapy in locally advanced rectal cancer" 대한외과학회 88 (88): 15-20, 2015

18 Smith JD, "Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy" 256 : 965-972, 2012

19 Uehara K, "Neoadjuvant treatment for locally advanced rectal cancer: a systematic review" 46 : 161-168, 2016

20 Patel UB, "Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes:MERCURY experience" 29 : 3753-3760, 2011

21 Maas M, "Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data" 11 : 835-844, 2010

22 Fiorica F, "Is it possible a conservative approach after radiochemotherapy in locally advanced rectal cancer (LARC)? A systematic review of the literature and meta-analysis" 50 : 98-108, 2019

23 Kim DW, "Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer?" 106 : 1694-1700, 2006

24 Appelt AL, "High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study" 16 : 919-927, 2015

25 Punt CJ, "Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials" 99 : 998-1003, 2007

26 Patel UB, "Comparison of magnetic resonance imaging and histopathological response to c hemoradiot herapy in locally advanced rectal cancer" 19 : 2842-2852, 2012

27 National Cancer Institute, "Common Terminology Criteria for Adverse Events (CTCAE), v5.0" NCI 2017

28 Liu S, "Can endorectal ultrasound, MRI, and mucosa integrity accurately predict the complete response for mid-low rectal cancer after preoperative chemoradiation? A prospective observational study from a single medical center" 61 : 903-910, 2018

29 Pucciarelli S, "Bowel function and quality of life after local excision or total mesorectal excision following chemoradiotherapy for rectal cancer" 104 : 138-147, 2017

30 Hallam S, "A systematic review of local excision after neoadjuvant therapy for rectal cancer: are ypt0 tumors the limit?" 59 : 984-997, 2016